This non-invasive, drug-free therapy uses advanced laser technology to target fungus beneath the nail without surgery or downtime
If you have side effects, concerns, or notice health changes, talk to your provider
In the coming weeks, Novo Nordisk is expected to release fresh Phase III data for its next-generation weight loss treatment CagriSema, which analysts say could be the next big thing in the obesity space
Approval was supported by pivotal vehicle-controlled phase 3 studies demonstrating higher rates of IGA success at week 4 versus vehicle, alongside a tolerability profile consistent with a nonsteroidal topical
These data are consistent with point mutations in the coding region
Cardiorenal syndrome: clinical diagnosis, molecular mechanisms and therapeutic strategies